Fulcrum Therapeutics Company

Fulcrum Therapeutics is a biotechnology company developing new medicines to deliver a new future to patients.
Technology: Cancer
Industry: PharmTech
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 1/1/2016
Employees Number: 51-100
Funding Status: IPO
Total Funding: 333499987
Estimated Revenue: $1B to $10B
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership